Unvaccinated individuals are the breeding grounds for the emergence of variants of interest (VOI) and variants of concern (VOC), which are more harmful than ADE in terms of the rate of occurrence
Disclosure of interest: Nothing to disclose Poster Session II - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.02 - ACUTE MANAGEMENT - Thrombolysis or thrombectomy P666 - ESOC25-2405 BRIDGING INTRAVENOUS THROMBOLYSIS IS ASSOCIATED WITH FASTER RECANALIZATION IN PATIENTS UNDERGOING THROMBECTOMY FOR ISCHAEMIC STROKE DUE TO LARGE ARTERY ATHEROSCLEROSIS Annahita Sedghi 1 , Daniel Kaiser 1 , Witold Polanski 1 , Martin Arndt 1 , Kristian Barlinn 1 , Volker Puetz 1 , Timo Siepmann 1 1 Dresden Neurovascular Center, Department of Neurology, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany Background and Aims: A recent study suggested that bridging intravenous thrombolysis (IVT) for large vessel occlusion LVO may alter clot architecture and facilitate rapid clot removal during thrombectomy, but this may vary by stroke etiology
Advice needed on b12 injections please :) Hi everyone, I was diagnosed with b12 deficiency in February this year (level was 121) and negative...
Quick AOD-9604 Dosing Summary AOD-9604 is a growth hormone fragment peptide administered via subcutaneous injection, typically dosed at 250-500 mcg daily in a fasted state
